SOX2 mediates cisplatin resistance in small‐cell lung cancer with downregulated expression of hsa‐miR‐340‐5p
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
SOX2
mediates cisplatin resistance in small‐cell lung cancer with downregulated expression of hsa‐miR‐340‐5p
Authors
Keywords
-
Journal
Molecular Genetics & Genomic Medicine
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-03-05
DOI
10.1002/mgg3.1195
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MicroRNA-130b targets PTEN to induce resistance to cisplatin in lung cancer cells by activating Wnt/β-catenin pathway
- (2018) Qiang Zhang et al. CELL BIOCHEMISTRY AND FUNCTION
- Upregulated microRNA-193a-3p is responsible for cisplatin resistance in CD44(+) gastric cancer cells
- (2018) So D. Lee et al. CANCER SCIENCE
- Progress and challenges in the treatment of small cell lung cancer
- (2017) Alfredo Tartarone et al. MEDICAL ONCOLOGY
- Sox2 inhibits Wnt-β-catenin signaling and metastatic potency of cisplatin-resistant lung adenocarcinoma cells
- (2017) Jinxi He et al. Molecular Medicine Reports
- MicroRNA-15b promotes proliferation and invasion of non-small cell lung carcinoma cells by directly targeting TIMP2
- (2017) Haowen Wang et al. ONCOLOGY REPORTS
- MicroRNA-29a functions as a potential tumor suppressor through directly targeting CDC42 in non-small cell lung cancer
- (2017) Yongqiang Li et al. Oncology Letters
- Management of Small Cell Lung Cancer
- (2015) Mehmet Altan et al. CANCER JOURNAL
- Therapeutic Priority of the PI3K/AKT/mTOR Pathway in Small Cell Lung Cancers as Revealed by a Comprehensive Genomic Analysis
- (2014) Shigeki Umemura et al. Journal of Thoracic Oncology
- Embryonic stem cell factors and pancreatic cancer
- (2014) Marta Herreros-Villanueva WORLD JOURNAL OF GASTROENTEROLOGY
- Systems biology of cisplatin resistance: past, present and future
- (2014) L Galluzzi et al. Cell Death & Disease
- Meta-analysis of human lung cancer microRNA expression profiling studies comparing cancer tissues with normal tissues
- (2012) Peng Guan et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer
- (2012) Charles M Rudin et al. NATURE GENETICS
- SOX2 Gene Regulates the Transcriptional Network of Oncogenes and Affects Tumorigenesis of Human Lung Cancer Cells
- (2012) Si Chen et al. PLoS One
- A Genetic Snapshot of Small Cell Lung Cancer: Figure 1.
- (2012) Rafael Rosell et al. Cancer Discovery
- Expression of the embryonic stem cell marker SOX2 in early-stage breast carcinoma
- (2011) Claudia Lengerke et al. BMC CANCER
- miR-200bc/429 cluster modulates multidrug resistance of human cancer cell lines by targeting BCL2 and XIAP
- (2011) Wei Zhu et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- MicroRNA 376c enhances ovarian cancer cell survival by targeting activin receptor-like kinase 7: implications for chemoresistance
- (2011) G. Ye et al. JOURNAL OF CELL SCIENCE
- MicroRNA-141 confers resistance to cisplatin-induced apoptosis by targeting YAP1 in human esophageal squamous cell carcinoma
- (2011) Yukako Imanaka et al. JOURNAL OF HUMAN GENETICS
- SOX2 gene amplification and protein overexpression are associated with better outcome in squamous cell lung cancer
- (2011) Theresia Wilbertz et al. MODERN PATHOLOGY
- Sox2 maintains self renewal of tumor-initiating cells in osteosarcomas
- (2011) U Basu-Roy et al. ONCOGENE
- Chemotherapy and Survival Benefit in Elderly Patients With Advanced Non–Small-Cell Lung Cancer
- (2010) Amy J. Davidoff et al. JOURNAL OF CLINICAL ONCOLOGY
- Expression of Pluripotent Stem Cell Reprogramming Factors by Prostate Tumor Initiating Cells
- (2010) Kyung-Mi Bae et al. JOURNAL OF UROLOGY
- SOX2 Is an Oncogene Activated by Recurrent 3q26.3 Amplifications in Human Lung Squamous Cell Carcinomas
- (2010) Thomas Hussenet et al. PLoS One
- Evidence That SOX2 Overexpression Is Oncogenic in the Lung
- (2010) Yun Lu et al. PLoS One
- Non-Small Cell Lung Cancer Cells Expressing CD44 Are Enriched for Stem Cell-Like Properties
- (2010) Elaine Lai-Han Leung et al. PLoS One
- The properties of tumor-initiating cells from a hepatocellular carcinoma patient's primary and recurrent tumor
- (2009) Xiao-Lan Xu et al. CARCINOGENESIS
- SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas
- (2009) Adam J Bass et al. NATURE GENETICS
- Sox2 Expression in Pulmonary Non-small Cell and Neuroendocrine Carcinomas
- (2009) Lynette M. Sholl et al. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
- MicroRNA Expression Profiling in Human Ovarian Cancer: miR-214 Induces Cell Survival and Cisplatin Resistance by Targeting PTEN
- (2008) H. Yang et al. CANCER RESEARCH
- Sox2 is important for two crucial processes in lung development: Branching morphogenesis and epithelial cell differentiation
- (2008) Cristina Gontan et al. DEVELOPMENTAL BIOLOGY
- Clinical significance of TTF-1 protein expression andTTF-1gene amplification in lung adenocarcinoma
- (2008) Justine A. Barletta et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Role of Chromosome 3q Amplification in Lung Cancer
- (2008) Jun Qian et al. Journal of Thoracic Oncology
- SOX2Silencing in Glioblastoma Tumor-Initiating Cells Causes Stop of Proliferation and Loss of Tumorigenicity
- (2008) Rosaria Maria Rita Gangemi et al. STEM CELLS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now